SCHEMBL12475734

SCHEMBL12475734

O=C(Cl)c1sc(-c2ccc(Cl)cc2)nc1C(Br)Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 7/20 0.50
ALDH1A1 P00352 6/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
GAA P10253 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.45
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
XDH P47989 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12475648 0.87 SMN1; SMN2 (0.50) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475719 0.87 RAB9A (0.50) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475343 0.87 RAB9A (0.65) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475500 0.83 SMN1; SMN2 (0.50) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475650 0.82 RAB9A (0.48) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475559 0.81 MAPT (0.48) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475436 0.80 GAA (0.52) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475304 0.80 NPC1 (0.52) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475713 0.80 TRPM8 (0.70) SMN1; SMN2RAB9ANPC1KDM4EPOLB
SCHEMBL12475339 0.80 MAPT (0.49) SMN1; SMN2RAB9ANPC1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012109573-A1 SUBSTITUTED THIAZOLES FOR USE AS ANTIVIRAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2012-08-16 WO disclosed